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Question 
How to protect and ideally advance systems for essential health services whilst rolling out 
the COVID-19 vaccines, diagnostics and therapeutics? 
 
• What are the opportunities COVID-19 vaccine roll out has to strengthen systems to 
deliver essential services? 
• What are the mitigation measures needed to ensure the vaccine roll out does not 
displace political space and resources (finance and staff) for essential services? 
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COVID-19 has significantly disrupted, suspended and diverted resources from essential health 
services which could cause a secondary health crisis and reverse decades of progress in global 
health. Health systems have been stretched, and in some cases collapsed, responding to the 
pandemic and will be stretched further with deployment of COVID-19 vaccines. Innovative adaptive 
measures have mitigated some of the impact of COVID-19 and presented opportunities for 
integrated service delivery such as testing for COVID-19 and other diseases. Countries are 
preparing to deploy COVID-19 vaccines at scale but the emphasis on speed and expediency over 
deliberate system-strengthening is coming at a cost of missing out on the benefits of long-lasting 
improvement that a systems approach could bring. Investment in effective and efficient service 
delivery for COVID-19 and essential health services will not only support the response to and 
recovery from COVID-19 but also strengthen the resilience of health systems to future challenges.  
This helpdesk report highlights a selection of resources focusing on protecting essential health 
services and opportunities for strengthening during rollout of COVID-19 vaccines, testing and 
treatments. A search was undertaken of leading actors in this space including global health 
initiatives (Global Fund, Gavi, Global Financing Facility (GFF), GPEI), the United Nations agencies 
including WHO and UNICEF, policy think tanks (Center for Global Development (CGD), Overseas 
Development Institute (ODI)) amongst others. Resources include blogs, policy papers, statements, 
country case studies, guidelines, reports and peer reviewed research reflecting discourse, 
mitigation measures and any evidence of impact to-date. The resources included are not an 
exhaustive list; they represent those that could be identified within the time allocated. Note that 
specific reference to mitigation measures and strengthening of essential health services during 
rollout of COVID-19 vaccines are limited and are generally considered within the wider context of 
the response and recovery to the COVID-19 pandemic and pandemic preparedness. 
A WHO Strategic Technical Advisory Group of Experts notes at this stage a key limitation of the 
available evidence is the lack of outcome data, particularly with control groups, that would be 
needed to fully evaluate the effectiveness of protection and recovery efforts (WHO, 2020b). Case 
studies are presented throughout the literature. There are opportunities to generate more and 
better evidence on what works to protect and promote more resilient health service provision and 
access during the response to COVID-19 (Krubiner et al., 2021). 
The literature discusses adaptive and innovative measures that essential health services have 
taken to maintain and strengthen essential health service delivery in response to the COVID-19 
pandemic and in the recovery phase. These include changes in the management of health workers 
and community health workers and changes in delivery of health services. Opportunities present 
and lessons can be learned from successful adaptive approaches to COVID-19 to protect and 
promote essential health services as part of the COVID-19 response and recovery efforts (Global 
Financing Facility, 2021b). This includes reimaging service delivery to be more effective and 
efficient reducing costs and improving access for the most vulnerable to reclaim the gains and 
accelerate progress for better health outcomes. Coordination with universal health coverage efforts 
will enable integrated service delivery and effective deployment of COVID-19 tools (Jakab et al., 
2021). The capacity of existing health systems will need to be increased to prevent disruption, 
draining or redirecting of limited resources to the pandemic response. 
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In March 2020, policies and public health efforts had not addressed the gendered impacts of 
COVID-19. Since then, the gendered dimensions of the response to and recovery from the COVID-
19 pandemic is being continually documented, assessed and analysed to inform and improve 
global and national policy responses by newly developed Working Groups and Initiatives such as 
the Gender and COVID-19 Working Group and The COVID-19 Gender and Development Initiative. 
Attention also needs to be given to the additional vulnerabilities experienced by marginalised social 
groups, including people living with disabilities. 
2. Indirect impact of COVID-19 on essential health services  
COVID-19 has suspended, disrupted and made inaccessible the provision of essential health 
services which could result in a secondary health crisis and reverse decades of progress in global 
health. We know from previous outbreaks and crises (Ebola, SARS, H1N1 outbreaks and the 
global financial crisis), and the indirect impacts of COVID-19 already observed, that indirect health 
effects are significant and could outweigh direct health impact (Chi et al., 2020). A successful 
COVID-19 policy should not be measured solely by the number of COVID-19 deaths averted but 
take a whole of health perspective.  
In January 2021 the WHO published its interim guidance on analysing and using routine data to 
monitor the effects of COVID-19 on essential health services (WHO, 2021a). This guide supports 
interim guidance published in June 2020 on Maintaining essential health services: operational 
guidance for the COVID-19 context, which provides an integrated framework to guide countries in 
their efforts to reorganise, adapt and maintain safe delivery of high-priority essential health services 
within the context of the pandemic (WHO, 2020d). The Global Financing Facility (GFF) also have 
a guidance note on the role of country platforms in maintaining essential services and delivering 
on the investment case in the time of COVID-19 (Global Financing Facility, 2020).  
Global efforts have examined if and to what extent essential health services have been disrupted 
so far during the COVID-19 pandemic. A second round of a WHO pulse survey during January to 
March 2021 on the continuity of essential health services during the COVID-19 pandemic reports 
global findings from the 135 countries and territories that participated in the key informant survey. 
Despite some evidence of essential health services restoration, over one year into the COVID-19 
pandemic substantial disruptions persist, with about 90% of countries still reporting one or more 
disruptions to essential health services (WHO, 2021c). There is no substantial change since the 
first survey conducted in the summer of 2020, however, within countries the magnitude and extent 
of disruptions has generally decreased. Gains and partial rebound in service provision is likely due 
to implementation of recommended policies and strategies for maintaining essential health 
services.  
In 2020, countries reported that, on average, about half of essential health services were disrupted 
compared to just over one third of services now being disrupted in the first three months of 2021 
(WHO, 2021c). Overall, primary care and rehabilitative, palliative and long-term care are more 
predominantly affected. Substantial disruptions span across all major health areas. Most frequently 
(reported in more than 40% of countries) disrupted services are for mental, neurological and 
substance use disorders and neglected tropical diseases. Services across other health areas are 
also disrupted in more than a third of countries. Service disruptions are perceived to be caused by 
a mix of supply and demand side factors. Health workforce-related issues are among the most 
commonly reported supply-side reasons linked to staff deployment to COVID-19 relief and 
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insufficient staff availability. Cancellation of elective care and changes to treatments policies are 
also reported. Most common demand-side reasons included: community fear/mistrust, decreases 
in OPD volume due to patients not presenting, travel restrictions and financial difficulties during 
the pandemic. In some countries, COVID-19 control may be contributing to increased barriers to 
accessing care (e.g., fear of getting infected, limitations in movement) and supply chain systems 
are also disrupted in nearly a third of countries. Many countries are using telehealth technologies 
to mitigate disruptions but limited access and technical capacities to use telehealth technologies 
are the most commonly reported barriers to use in countries. Further information, including from 
subnational, health facility and community levels should supplement findings to better quantify 
potential impact of disruptions over the short, medium and long term.  
Data from ongoing GFF-supported country monitoring has reaffirmed disruptions on the supply 
and demand-side of essential health services in low- and lower-middle income countries from 
which lessons can be learned to protect and promote essential health services as part of the 
COVID-19 response and recovery efforts (Global Financing Facility, 2021b). Rollout of COVID-19 
vaccines at scale are likely to place even more strain on health systems and resources. Impact on 
health financing – the ability to deliver essential health services and the ability of households to 
pay for these services - is likely to be significant in many of the poorest countries. This will require 
‘developing and implementing more effective and efficient models of delivering health care that will 
reduce costs and improve access for the poorest and more vulnerable populations’ (Global 
Financing Facility, 2021b). 
The Center for Global Development (CGD) present a framework for identifying the sources of 
indirect health effects of COVID-19 and provide a simple structure for analysts to calculate the 
overall “net health impact” of the pandemic (Chi et al., 2020). Sources of health system impact - 
funding, supply chain, health workforce, infrastructure, service provision, patient access, and 
‘covidisation’; diseases that could be affected; most disadvantaged populations affected; and 
short, medium and long-term risk if not mitigated – are categorised as a subset to the overall 
framework. CGD also have an open access inventory of resources on indirect health impacts that 
is continually being updated. 
A Global Fund report from 502 health facilities across Africa and Asia provides a snapshot on the 
impact of COVID-19 on HIV, tuberculosis (TB) and malaria services and systems for health (The 
Global Fund, 2021b). Disruptions on the supply-side include vulnerabilities in infection prevention 
measures, a lack of routine urgent care through employment, restrictions on movement and 
interrupted healthcare and on the demand side a wider reluctance to attend healthcare facilities 
because of fear of contracting COVID-19, along with increased stigma and discrimination, 
disruption in public transportation, lockdown or stay-at-home orders (The Global Fund, 2021b). 
The COVID-19 pandemic has severely disrupted access to TB services and is reversing the gains 
made towards ending TB (WHO, 2021b). Latest data collected by WHO from more than 80 
countries indicates that 1.4 million fewer people received care for TB in 2020 than in 2019, a 21% 
drop in TB notifications over this period. This could lead to an additional half a million TB deaths. 
The consequences of COVID-19 on access to TB services and on the determinants of TB, 
including poverty and food security, make it critical to adopt a multisectoral approach with 
engagement of affected communities, and civil society to stop further declines in case notifications 
and get on track to end TB. Global extreme poverty will rise for the first time in over 20 years, 
according to the World Bank, thereby causing significant increase in undernourishment, a major 
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determinant of TB. In this joint statement the WHO and CSTF-TB urge governments, partners and 
stakeholders to leverage domestic and external financial resources, including funding from The 
Global Fund and other bilateral and multilateral funding agencies, to introduce and scale-up 
innovative approaches for provision of TB services, including the use of digital technologies and 
dual testing for TB and COVID-19, and to strengthen airborne infection control, including 
procurement of personal protective equipment (PPE) for health workers and community workers 
involved in TB care and prevention activities.  
An estimated 11.5 million people affected by disruptions to anti-retroviral services for HIV/AIDS in 
36 countries between April and June 2020 and 75% of the Global Fund’s HIV/AIDS programmes 
report moderate to high levels of disruption to service delivery.  
A systematic review and meta-analysis found that global maternal and foetal outcomes have 
worsened during the COVID-19 pandemic, with an increase in maternal deaths, stillbirth, ruptured 
ectopic pregnancies and maternal depression (Chmielewska et al., 2021). This highlights the 
urgency behind prioritising safe, accessible, and equitable maternity care within the strategic 
response to this pandemic and in future health crises. The GFF estimates that access to life-saving 
health interventions for women, children and adolescents in 36 of the world’s poorest countries 
has dropped by as much as 25% due to COVID-19. That is equivalent to 82 million children not 
receiving oral rehydration, 4 million women losing access to care during childbirth, and 17 million 
children missing out on vaccinations. This threatens to reverse gains on the health of women, 
children and adolescents. The GFF Case for Investment calls for $1.2 billion funding to stop 
secondary health crisis for women and children due to the COVID-19 pandemic to help limit the 
damage and reclaim the gains (Global Financing Facility, 2021a). Gavi, WHO and UNICEF warn 
that at least 80 million children under the age of one risk missing out on routine vaccines for disease 
such as measles, polio and diphtheria (WHO, 2020c). 
Background paper 8 to The Independent Panel for Pandemic Preparedness and Response main 
report on Impact on Essential Health Services summarises the disruptions to essential health 
services with a deep dive into low- and middle-income country impacts (The Independent Panel 
for Pandemic Preparedness and Response, 2021b). A rational approach to public sector health 
spending and decision making during the COVID-19 pandemic based on ethics and equity 
principles is crucial to ensure that patients not infected by COVID-19 continue to get access to 
healthcare and that the services they need continue to be resourced (Williams et al., 2021). 
3. Rollout of COVID-19 tools  
Access to the COVID-19 Tools Accelerator (ACT-A) is co-convened by nine global health 
organisations which supports the development and equitable distribution of tests, treatments and 
vaccines, and since September 2020, the strengthening of health systems through the Health 
Systems Connector (HSC) pillar. HSC supports the integrated delivery of COVID-19 tools, rapidly 
addresses bottlenecks, and manages linkages and synergies with complementary activities for the 
delivery of essential health services and strengthening of health systems (WHO, 2021d). Noted 
though that ‘funds committed so far are skewed towards vaccines, with little for health systems’ 
and primarily dedicated to the procurement of two key tools: PPE and medical oxygen with a range 
of issues which exist that are not covered by the $9 billion health systems request – the cost of 
disposal of PPE, investments in electricity grids and pipes to make oxygen functional, the shortage 
of health workers, training and the need for infrastructure to support cold chains (Usher, 2021). 
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HSC has developed a collection of assessment tools to help governments partners and donors 
generate and use real-time data from those at the frontline to facilitate the scale-up and delivery of 
essential COVID-19 tools, guide strategies and plans to maintain essential health services (WHO, 
2021d). Kenya started using these tools at the end of 2020, interviewing facility managers and 
community health care workers in frontline services over one month and using the information to 
shape and strengthen their response to the pandemic and at the same time ensure continuity of 
services (WHO, 2021d). 
WHO’s COVID-19 Vaccine Introduction Readiness Assessment Tool provides support to countries 
in assessing programme readiness to introduce COVID-19 vaccines, identifying gaps and 
prioritising actions to be ready; and identifying opportunities for financial support. In anticipation of 
the availability of safe and effective vaccines for COVID-19, assessments of country readiness to 
deploy COVID-19 vaccines were rolled out in November 2020 jointly by the World Bank and WHO 
together with Gavi, the Global Vaccine Alliance; the Global Fund; UNICEF and governments (The 
World Bank, 2021). Initial findings from 128 countries as of March 2021 show that the world’s 
poorest countries are at varying degrees of readiness for vaccinating their populations against 
COVID-19. The tremendous impact of COVID-19 on health and economies, fear of highly 
contagious variants and pressure to start vaccinations have prompted many countries to prepare 
well enough to begin inoculating their populations when vaccines are available. Large-scale 
vaccination mobilisation provides opportunities to countries to sustainably strengthen the cold 
chain and introduce environmentally friendly options that could be of use well beyond the current 
crisis. However, the emphasis on speed and expediency over deliberate system-strengthening is 
coming at a cost of missing out on the benefits of long-lasting improvement that a systems 
approach could bring. Few countries are using the opportunity provided by the deployment of 
COVID-19 vaccines to strengthen health services and health systems and find long-lasting 
solutions for similar future challenges. With 47 African countries now rolling out COVID-19 
vaccines and over 17 million doses now given lessons are emerging from countries that have made 
strong progress including ‘existing health systems giving a strong base’ (Gavi, 2021a). 
Recognising that introduction of a new vaccine can have both positive and negative impacts on a 
country’s health system, WHO SAGE-endorsed six guiding principles for countries to follow in 
planning and implementing a new vaccine introduction whilst strengthening their overall 
immunisation programme and health system (WHO, 2020e). WHO and UNICEF recommend that 
‘activities should be integrated into the national primary health care (PHC) operational framework 
including: microplanning, using an evidence-based decision-making process to govern the 
introduction of the COVID-19 vaccine; strengthening human resources management; training for 
new vaccine introduction; establishing new contact points for vaccination across the life course; 
ensuring traceability systems and technologies are leveraged to ensure the integrity and efficiency 
of supply chains, improving and expanding integrated project management and the supply chain; 
enhancing integrated disease surveillance and adverse effects following immunisation monitoring 
and reporting systems; and  conducting integrated advocacy and communications activities to 
promote demand for vaccination as part of increasing overall demand and acceptability of all 
essential PHC services’ (WHO & UNICEF, 2020). 
New variants of concern threaten the effectiveness of existing COVID-19 vaccines, vaccine 
hesitancy slowing rollout, including in Africa, and interrupted and limited supply of COVID-19 tools 
(Gavi, 2021c; Vaccine Hesitancy Slows Africa’s COVID-19 Inoculation Drive | Reuters, 2021). Note 
that reasons for refusing a COVID-19 vaccine extend beyond just hesitancy (Gavi, 2021b; Ratzan 
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et al., 2021). As of 12 April, less than 2% of the 780 million COVID-19 vaccines given globally have 
been administered in Africa (Gavi, 2021a) and across 24 countries in Africa, only 11% of health 
facilities could conduct COVID-19 antigen rapid diagnostic tests, and only 8% could conduct PCR 
tests (The Global Fund, 2021b). 
4. Protecting essential health services during rollout of 
COVID-19 tools  
Adapting to the impact of COVID-19 on health service continuity with innovative approaches are 
enabling services to be implemented safely and mitigate negative impacts and sometimes even 
increase essential health service utilisation (The Global Fund, 2021b). These include the 
management of health and community workers and/or in changes in delivery strategies for health 
services unrelated to COVID-19. Such as facilities extending drug prescriptions to ensure patients 
have long-term and uninterrupted access to their medication; switching from a centralised 
approach to door-to-door distribution of long-lasting insecticidal nets (LLIN) against mosquitoes; 
but also, integration of services and especially for COVID-19 and TB which have much in common. 
Note that one size does not fit all with adaptive measures needing to be tailored to the country and 
local context. More funding is required though to scale up adaptive measures which are working, 
accelerating new approaches and innovations to improve service delivery and provide an 
opportunity for synergies in delivering health services, protecting frontline health workers and 
maintaining essential health services.  
WHO operational guidance for maintaining essential health services during an outbreak provides 
guidance on a set of immediate actions that countries should consider at national, regional and 
local level to recognise, strategically plan and coordinate action to maintain essential health service 
delivery mitigating the risk of system collapse (WHO, 2020d). Blanchet et al make the case for a 
rational approach to public sector health spending and decision making during and in the early 
recovery phase of the COVID-19 pandemic (Blanchet et al., 2020). A list of 120 essential non-
COVID-19 health interventions is presented, adapted from the model of health benefit packages 
developed by the Disease Control Priorities project. Focusing on routine healthcare services, this 
list guides governments and humanitarian agencies working to define national and local guidance 
for protecting essential routine services in low-income and middle-income countries and 
humanitarian settings and which interventions policymakers and donors need to protect from 
disinvestment.  
Background paper 8 to The Independent Panel for Pandemic Preparedness & Response’s main 
report published in May 2021 (The Independent Panel for Pandemic Preparedness and Response, 
2021a) on Impact on essential health services highlights experiences of an emerging evidence 
base, drawn from case studies from multiple countries, of protection and recovery efforts (The 
Independent Panel for Pandemic Preparedness and Response, 2021b). A 2020 meeting of the 
WHO Strategic Technical Advisory Group of Experts note that a key limitation of the available 
evidence is the lack of outcome data, particularly with control groups, that would be needed to fully 
evaluate the effectiveness of these approaches and that support for data collection, aggregation 
and knowledge translation mechanisms coordinated at the global level are required to support real-
time learning on disruptions and effective mitigation strategies across countries (WHO, 2020b). 
The WHO issued an Information note on 5 May 2021 intended to assist national TB programmes 
and health personnel worldwide to maintain essential TB services during the COVID-19 pandemic 
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and in the recovery phase and what services can be leveraged across both diseases including 
basic infection prevention and control, contact tracing and household and community-based care 
(WHO, 2021e). A Global Fund COVID-19 Information Note also provides guidance to countries on 
preparing and updating plans to mitigate the impact of COVID-19 on TB services (The Global Fund, 
2020). Specifically, to identify opportunities for the response to TB to benefit from the response to 
COVID-19, including enhanced surveillance for both diseases and scale up of the promotion and 
protection of human rights and combating stigma and discrimination. 
A CGD Brief provides a snapshot of the existing and evolving evidence as it relates to key health 
services and outcomes for women and girls in low- and middle-income countries, focusing primarily 
on sexual and reproductive health and rights (Krubiner et al., 2021). The paper examines some 
ways national governments have sought to maintain provision of essential health services and 
reviews the extent to which donor institutions have prioritised financial, technical and other forms 
of support to mitigate disruptions. Areas of opportunity for future action that donors and 
governments should pursue to address indirect harms to women’s and girl’s health during and 
beyond the COVID-19 crisis include improving data collection and sharing, with explicit attention 
to gender and intersectional disadvantage, and evaluating what works to mitigate gendered indirect 
effects, especially integrated approaches. 
An analysis, based on a rapid evidence assessment by the Social Science in Humanitarian Action 
Platform, on mitigating negative impacts on other areas of health emphasises the additional 
vulnerabilities experienced by marginalised social groups, including people living with disabilities 
(Hrynick et al., 2021). In the short-term, there is a need to embed the COVID-19 response within 
integrated health systems approaches feeding into longer-term strategies to strengthen health 
systems, expand universal health care coverage and address the social determinants of health.  
Attention has been given on how to prioritise between patient groups for COVID-19 vaccination 
and how to ensure equity but these decisions must balance the COVID-19 response with the need 
to invest in other healthcare (Williams et al., 2021). Here principles of good priority setting including 
evidence-based and transparent decision-making, participation of stakeholders and a focus on the 
implementation of decisions can be helpful.  
5. Promoting essential health services during rollout of 
COVID-19 tools 
A blog from, UHC2030 co-chairs highlights that ‘just as everyone, everywhere should have access 
to quality, safe, effective and affordable COVID-19 tests, treatments and vaccines, they should 
also have access to quality and affordable health services across their health needs’ (Cuevas 
Barron & Koonin, 2021). In some countries, COVID-19 has hampered the ability of health systems 
to deliver on essential health services and even exposed a relative neglect of core public health 
functions - ‘building better’ must mean investing in health systems in a joined-up way. 
A key HSC priority for 2021 is to manage linkages and synergies with complementary activities for 
the delivery of essential health services and strengthening of health systems to help meet the 
primary objective of enabling integrated delivery and effective deployment of COVID-19 tools 
(Jakab et al., 2021). Complementary activities are: 
   
 
9 
• Coordination with the ongoing efforts to support a comprehensive COVID-19 response and 
address the secondary health crisis 
• Coordination with the broader complementary health systems work, including the 
UHC2030 and UHC partnership 
• Increase of capacity of existing health systems and prevention of disruption, draining or 
redirecting of limited resources to the pandemic response 
Background paper 8 to The Independent Panel for Pandemic Preparedness & Response’s main 
report (The Independent Panel for Pandemic Preparedness and Response, 2021a) on the Impact 
on essential health services recommends that to minimise disruptions to essential services and 
protect health workers during future health emergencies to (1) better invest in, better prepare, and 
better protect the health workforce; (2) build the evidence-base for emerging health systems 
adaptations that could improve health systems resilience and pandemic response, as well as 
efficient service delivery in peace time; and (3) investment in foundational effective prevention 
systems to protect essential health services. (The Independent Panel for Pandemic Preparedness 
and Response, 2021b). 
Most public health efforts are concentrated on improving systems’ capacity to respond to the 
COVID-19 pandemic but tend to overlook gender-specific experiences and challenges missing an 
opportunity to design and implement policies and systems more effectively. Existing policies may 
even deepen structural inequalities. A rapid literature review by the Maintains Programme details 
successful interventions that could enable adaptive approaches to respond to gender concerns 
relevant to the COVID-19 pandemic including the concern of transactional sex for vaccines 
(Jhunjhunwala & Padmanabhan, 2020).  
A working paper by CGD addresses the gendered impact of COVID-19 focusing on how the 
pandemic has been affected women’s and girl’s health (Krubiner et al., 2021). The paper concludes 
with six opportunities and preliminary recommendations of promising strategies that donors and 
governments could follow to address the indirect harms to their health. This includes building on 
the momentum of health innovations during the COVID-19 crisis during the response and recovery 
phase by integrating service delivery, including new digital models and tools into the larger health 
systems to realise their full potential, to better meet the broader health needs of women and girls. 
Note that given that COVID-19 has amplified pre-existing vulnerabilities and inequities the pre-
COVID evidence on health systems strengthening still applies.  
An influential commentary on COVID-19: The Gendered Impacts of the Outbreak published in The 
Lancet in March 2020 (Wenham et al., 2020) led to the creation of an international Gender and 
COVID-19 Working Group bringing academics together to conduct real-time gender analysis to 
identify and document the gendered dynamics of COVID-19 and gaps in preparedness and 
response. Outputs include development of a tool to describe differences in the secondary health 
effects of the COVID-19 pandemic across genders to help decision makers address gender 
disparities in pandemic preparedness, response, and recovery plans (‘How to Create a Gender 
Responsive Pandemic Plan Addressing the Secondary Effects of COVID-19 > Gender & Covid-
19’, n.d.). The CGD has also set up a new global research hub: The COVID-19 Gender and 
Development Initiative.  
A Stop TB Partnership report highlights the opportunity to leverage investments in the ACT-A to 
strengthen national TB and TB/COVID-19 responses, as the mechanism seeks to find and fund 
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solutions and improve disease surveillance, especially in regions and countries with weak health 
systems (Stop TB Partnership, 2020). The commodities and tools developed for COVID-19 should 
stimulate the diversification of tools, including: 
• The development of multiplexed point-of-care testing (xPOCT) diagnostic tools, which will 
support options such as bidirectional screening of COVID-19 and TB 
• Increased access to scientific data through proliferation of open-source systems 
• Challenging the elasticity of the current patent system 
India’s experience shows that the COVID-19 pandemic provides an opportunity to fight TB and 
COVID-19 at the same time by increasing investments in the common tools, health workers and 
systems for health needed for both diseases (The Global Fund, 2021a). India developed a plan to 
integrate TB and COVID-19, including screening programmes – screening of TB patients for 
COVID-19 and COVID-19 patients for TB (known as bi-directional screening) to increase 
surveillance and laboratory services. Officials and heath community workers say the fight against 
COVID-19 is now providing an opportunity to better fight TB with the expansion of molecular testing 
and changes in social norms. For example in Mumbai, India a new technology – Truelab™ which 
is an innovative, chip-based, multi-disease diagnostic platform is being used to expand COVID-19 
testing and to facilitate TB screening of people with COVID-19 symptoms (FIND and IHF Partner 
with MCGM to Expand Access to COVID-19 and Tuberculosis Dual Testing in Mumbai, 2021). 
A WHO report documents the significant role played by polio eradication personnel during the 
pandemic and urges strong action to sustain this network to deliver essential public health services 
after polio is eradicated (WHO, 2020a). The polio programme plans to use its expertise in 
immunisation to help deliver COVID-19 vaccines as well as reach at least 80 million children who 
have missed out on vital vaccines during the pandemic. This accelerates the “polio transition” 
process to serve other public health goals, health emergencies and health systems strengthening 
whilst simultaneously providing support to countries to develop plans on how polio capabilities can 
be sustained (Polio Global Eradication Initiative, 2021). 
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